These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2645824

  • 1. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials.
    Diener HC, Scholz E, Dichgans J, Gerber WD, Jäck A, Bille A, Niederberger U.
    Ann Neurol; 1989 Feb; 25(2):125-30. PubMed ID: 2645824
    [Abstract] [Full Text] [Related]

  • 2. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R, Lichtenthal A, Wöhling H, Graf C, Brixius K.
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 4. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis.
    Gerber WD, Diener HC, Scholz E, Niederberger U.
    Cephalalgia; 1991 Feb; 11(1):37-45. PubMed ID: 2036669
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 6. The pattern--reversal visual evoked potentials in children with migraine with aura and without aura.
    Boćkowski L, Sobaniec W, Smigielska-Kuzia J, Kułak W, Sołowiej E.
    Rocz Akad Med Bialymst; 2003 Apr; 48():154-7. PubMed ID: 14737964
    [Abstract] [Full Text] [Related]

  • 7. [Beta-blockers and migraine].
    Massiou H, Bousser MG.
    Pathol Biol (Paris); 1992 Apr; 40(4):373-80. PubMed ID: 1353872
    [Abstract] [Full Text] [Related]

  • 8. Nifedipine in migraine and tension headache: a randomised double blind crossover study.
    Shukla R, Garg RK, Nag D, Ahuja RC.
    J Assoc Physicians India; 1995 Nov; 43(11):770-2. PubMed ID: 8773038
    [Abstract] [Full Text] [Related]

  • 9. Visual evoked potential & brainstem auditory evoked potentials in acute attack & after the attack of migraine.
    Kochar K, Srivastava T, Maurya RK, Jain R, Aggarwal P.
    Electromyogr Clin Neurophysiol; 2002 Nov; 42(3):175-9. PubMed ID: 11977431
    [Abstract] [Full Text] [Related]

  • 10. [Calcium channel blockers and prevention of migraine].
    Montastruc JL, Senard JM.
    Pathol Biol (Paris); 1992 Apr; 40(4):381-8. PubMed ID: 1353873
    [Abstract] [Full Text] [Related]

  • 11. Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study.
    Siniatchkin M, Andrasik F, Kropp P, Niederberger U, Strenge H, Averkina N, Lindner V, Stephani U, Gerber WD.
    Cephalalgia; 2007 Sep; 27(9):1024-32. PubMed ID: 17680819
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol].
    Wörz R, Reinhardt-Benmalek B, Föh M, Grotemeyer KH, Scharafinski HW.
    Fortschr Med; 1992 May 20; 110(14):268-72. PubMed ID: 1351025
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis.
    Streng A, Linde K, Hoppe A, Pfaffenrath V, Hammes M, Wagenpfeil S, Weidenhammer W, Melchart D.
    Headache; 2006 May 20; 46(10):1492-502. PubMed ID: 17115982
    [Abstract] [Full Text] [Related]

  • 14. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD, Schellenberg R, Thom M, Haufe C, Bölsche F, Wedekind W, Niederberger U, Soyka D.
    Funct Neurol; 1995 May 20; 10(1):27-35. PubMed ID: 7649498
    [Abstract] [Full Text] [Related]

  • 15. Visual evoked potentials in migraine.
    Spreafico C, Frigerio R, Santoro P, Ferrarese C, Agostoni E.
    Neurol Sci; 2004 Oct 20; 25 Suppl 3():S288-90. PubMed ID: 15549564
    [Abstract] [Full Text] [Related]

  • 16. Visual and auditory evoked potentials in migraine.
    Drake ME, Pakalnis A, Hietter SA, Padamadan H.
    Electromyogr Clin Neurophysiol; 1990 Oct 20; 30(2):77-81. PubMed ID: 2311571
    [Abstract] [Full Text] [Related]

  • 17. [Beta blockers in migraine prophylaxis].
    Shimizu T.
    Brain Nerve; 2009 Oct 20; 61(10):1125-30. PubMed ID: 19882938
    [Abstract] [Full Text] [Related]

  • 18. Nitroglycerin sensitises in healthy subjects CNS structures involved in migraine pathophysiology: evidence from a study of nociceptive blink reflexes and visual evoked potentials.
    Di Clemente L, Coppola G, Magis D, Gérardy PY, Fumal A, De Pasqua V, Di Piero V, Schoenen J.
    Pain; 2009 Jul 20; 144(1-2):156-61. PubMed ID: 19457613
    [Abstract] [Full Text] [Related]

  • 19. Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study.
    Olsson JE, Behring HC, Forssman B, Hedman C, Hedman G, Johansson F, Kinnman J, Pålhagen SE, Samuelsson M, Strandman E.
    Acta Neurol Scand; 1984 Sep 20; 70(3):160-8. PubMed ID: 6391066
    [Abstract] [Full Text] [Related]

  • 20. Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study.
    Kangasniemi P, Hedman C.
    Cephalalgia; 1984 Jun 20; 4(2):91-6. PubMed ID: 6428749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.